stock.name

Rocket Pharmaceuticals Inc

RCKT

Market Cap$2.51B
Close$

Compare Rocket Pharmaceuticals

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Rocket Pharmaceuticals IncRocket Pharmaceuticals Inc00%---
marketMarket Avg59.61.27%31%6.41
HealthcareHealthcare Avg62.31.27%15%7.30.9
$30.89

Current Fair Value

13.4% upside

Undervalued by 13.4% based on the discounted cash flow analysis.

Share Statistics

Market cap$2.51 Billion
Enterprise Value-
Dividend Yield$0.0 (0.0%)
Earnings per Share$0.0
Beta1.87
Outstanding Shares90,504,248
Avg 30 Day Volume860,451

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio0.0
PEG-
Price to Sales-
Price to Book Ratio-
Enterprise Value to Revenue-
Enterprise Value to EBIT-
Enterprise Value to Net Income-
Total Debt to Enterprise-
Debt to Equity-

Revenue Sources

No data

ESG Score

No data

About Rocket Pharmaceuticals Inc

151 employees
CEO: Gaurav Shah